Minerva Neurosciences (NERV) Tops Q2 EPS by 5c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Seaport Global Securities Downgrades FOX Corp. (FOXA) to Neutral
• Atlassian results seen as 'game changer' for AI kills software worries